United States · FDA National Drug Code directory
JYNNEOS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50632-024_b115e2e7-c24d-4306-b26c-8696ac61c9f7
- Product NDC
- 50632-024
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen
- Labeler
- Bavarian Nordic A/S
- Marketing category
- BLA
- Marketing start / end (source format)
- 20251231
- Source listing expiry
- 20261231
Source-listed ingredients
- VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN — 50000000 1/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 VIAL in 1 CARTON (50632-024-02) / .5 mL in 1 VIAL (50632-024-04) · 50632-024-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →